Proteomics Market Research Report - Forecast till 2027

Proteomics Market Research Report: by Equipment (Chromatography, Mass Spectroscopy, Protein Microarray, Others), by Services (Laboratory Services, Data Analysis & Services), by Application (Drug Discovery, Clinical Diagnosis, Others) - Forecast Till 2027

ID: MRFR/LS/5465-HCR | February 2021 | Region: Global | 90 pages

Proteomics Market Scenario:


Proteomics Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 23.2 Billion in 2017 and is projected to grow at a CAGR of 14.1% over the forecast period. Proteomes are a set of proteins which are produced in a system, organism, or any biological entity. Study of proteomes is known as proteomics. It is used in various applications, like investigation of protein expression, transcriptional & post transcriptional studies, metabolic pathways, protein interaction in diseases, etc.


The factors such as increasing research & development activities in the healthcare industry, rising demand for personalized medicines, rising number of approvals of personalized medicines and increasing activities of drug discovery are expected to propel the growth of the market. According to Foley & Lardner LLP, Food and Drug Administration (FDA) approved 16 new personalized medicine therapies in 2017. However, the high cost of devices and lack of skilled researchers can hamper the market growth over the forecast period.


Segmentation:


The Proteomics Market has been segmented into equipment, service and applicationThe market, on the basis of equipment, has been segmented into chromatography, mass spectroscopy, protein microarray, x-ray crystallography, protein fractionation and others.The market, by services, has been segmented into laboratory services and data analysis & services. The laboratory services segment accounted for the largest market share owing to its benefits in effective diagnosis and research for drug discovery. Data analysis and services is expected to register the highest CAGR owing to increasing demand for data analytics.The market, by application, has been segmented into drug discovery, clinical diagnosis and others.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Proteomics Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European Proteomics Market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The Proteomics Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Proteomics market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key players:


GENERAL ELECTRIC COMPANY, Bio-Rad Laboratories, Inc., Danaher, Siemens Ltd., Thermo Fisher Scientific Inc. Inc., Agilent Technologies, Inc., Genzyme Corporation, Biognosys AG, Bruker, Luminex Corporation, Merck KGaA, PerkinElmer Inc., WATERS, Caprion Biosciences Inc. and others are some of the key players in the Global Proteomics Market.


Regional Market Summary


Global Proteomics Market Share (%), by Region, 2017


Source: Centers for Disease Control and Prevention (CDC), Eurostat, White Papers, Company Presentations, Annual Reports


Geographically, the Americas is anticipated to dominate the global proteomics market owing to rising funding from government, rising awareness regarding applications of proteomics, cost effectiveness and increasing demand for personalized medicines. According to a report published in a journal named Leukemia Research in November 2017, personalized medicines improve life of cancer patients by 7 months at USD 32,000.


Europe is expected to hold the second largest position in the Global Proteomics Market. The market growth in this region is attributed to rising cancer research activities and government support. The proteomics market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and the Rest of the Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the increasing demand for personalized medicine due to rising prevalence of cancer and other such diseases and presence of large number of manufacturers of personalized medicines in the region. According to a report published by the National Institute of Cancer Prevention and Research (NICPR), around 2.25 million people in India are living with cancer in 2018.


The Middle East & Africa are expected to hold the least share of the market. The market growth in this region is expected to be driven by a developing healthcare infrastructure.


Proteomics Market, by Equipment:



  • Chromatography

  • Mass Spectroscopy

  • Protein Microarray

  • X-ray Crystallography

  • Protein Fractionation

  • Others


Proteomics Market, by Services:



  •       Laboratory Service

  •       Data Analysis and Services


Proteomics Market, by Application:



  •      Drug Discovery

  •      Clinical Diagnosis

  •      Others


Proteomics Market, by Region:



  • Americas

    •   North America

      •  US

      •  Canada



    •  South America



  • Europe

    •  Western Europe

      •  Germany

      •  France

      •  Italy

      •  Spain

      •  UK

      •  Rest of Western Europe



    •   Eastern Europe



  • Asia-Pacific

    •  Japan

    •  China

    •  India

    •  Australia

    •  South Korea

    •  Rest of Asia-Pacific



  • The Middle East & Africa

    •  Middle East

    •  Africa




Proteomics Market, by Key Players:



  •       Hoffmann-La Roche Ltd

  •       GENERAL ELECTRIC COMPANY

  •       Bio-Rad Laboratories, Inc.

  •       Danaher

  •       Siemens Ltd.

  •       Thermo Fisher Scientific Inc. Inc.

  •       Agilent Technologies, Inc.

  •       Genzyme Corporation

  •       Biognosys AG

  •       Bruker

  •       Luminex Corporation

  •       Merck KGaA

  •       PerkinElmer Inc.

  •       WATERS

  •       Caprion Biosciences Inc.


Intended Audience:



  • Pharmaceutical Companies

  • Research and Development Organization

  • Oncology Laboratories

  • Healthcare Organizations

  • Academics and Research Institutes



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2017: USD 23.2 Billion
  • 2027: Significant Value
  •   CAGR   14.1% (2018-2023)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Equipment, Service and Application
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   GENERAL ELECTRIC COMPANY, Bio-Rad Laboratories, Inc., Danaher, Siemens Ltd., Thermo Fisher Scientific Inc. Inc., Agilent Technologies, Inc., Genzyme Corporation, Biognosys AG, Bruker, Luminex Corporation, Merck KGaA, PerkinElmer Inc., WATERS, Caprion Biosciences Inc.
      Key Market Opportunities

  • Increasing research & development activities in the healthcare industry
  • Rising demand for personalized medicines
  • Rising number of approvals of personalized medicines
  • Iincreasing activities of drug discovery
  •   Key Market Drivers   Rising prevalence of cancer and associated genetic disorders


    Frequently Asked Questions (FAQ) :


    Proteomes are a set of proteins which are produced in a system, organism, or any biological entity. Study of proteomes is known as proteomics.

    Proteomics used in various applications, like investigation of protein expression, transcriptional & post transcriptional studies, metabolic pathways, protein interaction in diseases, etc.

    Global Proteomics Market is anticipated that the market held a valuation of USD 23.2 Billion in 2017

    Proteomics Market is projected to grow at a CAGR of 14.1% by 2023

    The factors such as increasing research & development activities in the healthcare industry, rising demand for personalized medicines, rising number of approvals of personalized medicines and increasing activities of drug discovery are expected to propel the growth of the market.

    Geographically, the Americas is anticipated to dominate the global proteomics market owing to rising funding from government, rising awareness regarding applications of proteomics, cost effectiveness and increasing demand for personalized medicines.

    GENERAL ELECTRIC COMPANY, Bio-Rad Laboratories, Inc., Danaher, Siemens Ltd., Thermo Fisher Scientific Inc. Inc., Agilent Technologies, Inc., Genzyme Corporation, Biognosys AG, Bruker, Luminex Corporation, Merck KGaA, PerkinElmer Inc., WATERS, Caprion Biosciences Inc. and others are some of the key players in the Global Proteomics Market.

    Table of Contents:

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Equipment Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Proteomics Market, by Equipment

    6.1 Introduction

    6.2 Chromatography

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3 Mass Spectroscopy

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.4 Protein Microarray

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.5 X-ray Crystallography

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.6 Protein Fractionation

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.7 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 7. Global Proteomics Market, by Service

    7.1 Introduction

    7.2 Laboratory Service

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3 Data Analysis and Services

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 8. Global Proteomics Market, by Application

    8.1 Introduction

    8.2 Drug Discovery

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3 Clinical Diagnosis

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 9. Global Proteomics Market, by Region

    9.1 Introduction

    9.2 Americas

    9.2.1 North America

    9.2.1.1 US

    9.2.1.2 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 Italy

    9.3.1.4 Spain

    9.3.1.5 UK

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia-Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 South Korea

    9.4.6 Rest of Asia-Pacific

    9.5 Middle East & Africa

    9.5.1 Middle East

    9.5.2 Africa

    Chapter 10. Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies

    Chapter 11. Company Profiles

    11.1 GENERAL ELECTRIC COMPANY

    11.1.1 Company Overview

    11.1.2 Equipment Overview

    11.1.3 Financials Overview

    11.1.4 Key Developments

    11.1.5 SWOT Analysis

    11.2 Bio-Rad Laboratories, Inc.

    11.2.1 Company Overview

    11.2.2 Equipment Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 DANAHER

    11.3.1 Company Overview

    11.3.2 Equipment Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 Siemens Ltd.

    11.4.1 Company Overview

    11.4.2 Equipment Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 Thermo Fisher Scientific Inc.

    11.5.1 Company Overview

    11.5.2 Equipment Overview

    11.5.3 Financial overview

    11.5.4 Key Developments

    11.5.5 SWOT Analysis

    11.6 Agilent Technologies, Inc.

    11.6.1 Company Overview

    11.6.2 Equipment Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.6.5 SWOT Analysis

    11.7 Genzyme Corporation

    11.7.1 Overview

    11.7.2 Equipment Overview

    11.7.3 Financial Overview

    11.7.4 Key Developments

    11.7.5 SWOT Analysis

    11.8 Biognosys AG

    11.8.1 Overview

    11.8.2 Equipment Overview

    11.8.3 Financials

    11.8.4 Key Developments

    11.8.5 SWOT Analysis

    11.9 Bruker

    11.9.1 Overview

    11.9.2 Equipment Overview

    11.9.3 Financials

    11.9.4 Key Developments

    11.9.5 SWOT Analysis

    11.10 Luminex Corporation

    11.10.1 Overview

    11.10.2 Equipment Overview

    11.10.3 Financials

    11.10.4 Key Developments

    11.10.5 SWOT Analysis

    11.11 Merck KGaA

    11.11.1 Overview

    11.11.2 Equipment Overview

    11.11.3 Financial Overview

    11.11.4 Key Developments

    11.11.5 SWOT Analysis

    11.12 PerkinElmer Inc.

    11.12.1 Overview

    11.12.2 Equipment Overview

    11.12.3 Financials

    11.12.4 Key Developments

    11.12.5 SWOT Analysis

    11.13 WATERS

    11.13.1 Overview

    11.13.2 Equipment Overview

    11.13.3 Financials

    11.13.4 Key Developments

    11.13.5 SWOT Analysis

    11.14 Caprion Biosciences Inc.

    11.14.1 Overview

    11.14.2 Equipment Overview

    11.14.3 Financials

    11.14.4 Key Developments

    11.14.5 SWOT Analysis

    Chapter 12 MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s View point

    12.1.2 Unmet Needs of the Market

    12.2 Key Companies to Watch

    12.3 Predictions for the Proteomics Industry

    Chapter 13. Appendix

    LIST OF TABLES

    Table 1 Global Proteomics Market Synopsis, 2020-2027

    Table 2 Global Proteomics Market Estimates and Forecast, 2020-2027 (USD Million)

    Table 3 Global Proteomics Market, by Region, 2020-2027 (USD Million)

    Table 4 Global Proteomics Market, by Equipment, 2020-2027 (USD Million)

    Table 5 Global Proteomics Market, by Services, 2020-2027 (USD Million)

    Table 6 Global Proteomics Market, by Application, 2020-2027 (USD Million)

    Table 7 North America: Proteomics Market, by Equipment, 2020-2027 (USD Million)

    Table 8 North America: Proteomics Market, by Services, 2020-2027 (USD Million)

    Table 9 North America: Proteomics Market, by Application, 2020-2027 (USD Million)

    Table 10 US: Proteomics Market, by Equipment, 2020-2027 (USD Million)

    Table 11 US: Proteomics Market, by Services, 2020-2027 (USD Million)

    Table 12 US: Proteomics Market, by Application, 2020-2027 (USD Million)

    Table 13 Canada: Proteomics Market, by Equipment, 2020-2027 (USD Million)

    Table 14 Canada: Proteomics Market, by Services, 2020-2027 (USD Million)

    Table 15 Canada: Proteomics Market, by Application, 2020-2027 (USD Million)

    Table 16 South America: Proteomics Market, by Equipment, 2020-2027 (USD Million)

    Table 17 South America: Proteomics Market, by Services, 2020-2027 (USD Million)

    Table 18 South America: Proteomics Market, by Application, 2020-2027 (USD Million)

    Table 19 Europe: Proteomics Market, by Equipment, 2020-2027 (USD Million)

    Table 20 Europe: Proteomics Market, by Services, 2020-2027 (USD Million)

    Table 21 Europe: Proteomics Market, by Application, 2020-2027 (USD Million)

    Table 22 Western Europe: Proteomics Market, by Equipment, 2020-2027 (USD Million)

    Table 23 Western Europe: Proteomics Market, by Services, 2020-2027 (USD Million)

    Table 24 Western Europe: Proteomics Market, by Application, 2020-2027 (USD Million)

    Table 25 Eastern Europe: Proteomics Market, by Equipment, 2020-2027 (USD Million)

    Table 26 Eastern Europe: Proteomics Market, by Services, 2020-2027 (USD Million)

    Table 27 Eastern Europe: Proteomics Market, by Application, 2020-2027 (USD Million)

    Table 28 Asia-Pacific: Proteomics Market, by Equipment, 2020-2027 (USD Million)

    Table 29 Asia-Pacific: Proteomics Market, by Services, 2020-2027 (USD Million)

    Table 30 Asia-Pacific: Proteomics Market, by Application, 2020-2027 (USD Million)

    Table 31 Middle East & Africa: Proteomics Market, by Equipment, 2020-2027 (USD Million)

    Table 32 Middle East & Africa: Proteomics Market, by Services, 2020-2027 (USD Million)

    Table 33 Middle East & Africa: Proteomics Market, by Application, 2020-2027 (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Market Structure for Global Proteomics Market

    Figure 3 Market Dynamics for Global Proteomics Market

    Figure 4 Global Proteomics Market Share, by Equipment, 2020

    Figure 5 Global Proteomics Market Share, by Services, 2020

    Figure 6 Global Proteomics Market Share, by Application, 2020

    Figure 7 Global Proteomics Market Share, by Region, 2020

    Figure 8 North America: Proteomics Market Share, by Country, 2020

    Figure 9 Europe: Proteomics Market Share, by Country, 2020

    Figure 10 Asia-Pacific: Proteomics Market Share, by Country, 2020

    Figure 11 Middle East & Africa: Proteomics Market Share, by Country, 2020

    Figure 12 Global Proteomics Market: Company Share Analysis, 2020 (%)

    Figure 13 GENERAL ELECTRIC COMPANY: Key Financials

    Figure 14 GENERAL ELECTRIC COMPANY: Segmental Revenue

    Figure 15 GENERAL ELECTRIC COMPANY: Geographical Revenue

    Figure 16 Bio-Rad Laboratories, Inc.: Key Financials

    Figure 17 Bio-Rad Laboratories, Inc.: Segmental Revenue

    Figure 18 Bio-Rad Laboratories, Inc.: Geographical Revenue

    Figure 19 DANAHER: Key Financials

    Figure 20 DANAHER: Segmental Revenue

    Figure 21 DANAHER: Geographical Revenue

    Figure 22 Siemens Ltd.: Key Financials

    Figure 23 Siemens Ltd.: Segmental Revenue

    Figure 24 Siemens Ltd.: Geographical Revenue

    Figure 25 Thermo Fisher Scientific Inc.: Key Financials

    Figure 26 Thermo Fisher Scientific Inc.: Segmental Revenue

    Figure 27 Thermo Fisher Scientific Inc.: Geographical Revenue

    Figure 28 Agilent Technologies, Inc.: Key Financials

    Figure 29 Agilent Technologies, Inc.: Segmental Revenue

    Figure 30 Agilent Technologies, Inc.: Geographical Revenue

    Figure 31 Genzyme Corporation: Key Financials

    Figure 32 Genzyme Corporation: Segmental Revenue

    Figure 33 Genzyme Corporation: Geographical Revenue

    Figure 34 Biognosys AG: Key Financials

    Figure 35 Biognosys AG: Segmental Revenue

    Figure 36 Biognosys AG: Geographical Revenue

    Figure 37 Bruker: Key Financials

    Figure 38 Bruker: Segmental Revenue

    Figure 39 Bruker: Geographical Revenue

    Figure 40 Luminex Corporation: Key Financials

    Figure 41 Luminex Corporation: Segmental Revenue

    Figure 42 Luminex Corporation: Geographical Revenue

    Figure 43 Merck KGaA: Key Financials

    Figure 44 Merck KGaA: Segmental Revenue

    Figure 45 Merck KGaA: Geographical Revenue

    Figure 46 PerkinElmer Inc.: Key Financials

    Figure 47 PerkinElmer Inc.: Segmental Revenue

    Figure 48 PerkinElmer Inc.: Geographical Revenue

    Figure 49 WATERS: Key Financials

    Figure 50 WATERS: Segmental Revenue

    Figure 51 WATERS: Geographical Revenue

    Figure 52 Caprion Biosciences Inc.: Key Financials

    Figure 53 Caprion Biosciences Inc.: Segmental Revenue

    Figure 54 Caprion Biosciences Inc.: Geographical Revenue